<!DOCTYPE html>
<html lang="en">
	<head>
		<meta charset="utf8">
		<meta name="viewport" content="width=device-width, initial-scale=1">
		<title>Risteys – T2D_INCLAVO – detailed case counts by code</title>
		<style type="text/css">
body {
	font-family: sans-serif;
}
.bar-plot-full {
	width: 8rem;
	border-radius: 0.1rem;
	background-color: #f2f2f2;
}
.bar-plot-full div {
	background-color: #c7c7c7;
	height: 1rem;
	border-radius: 0.1rem;
}
		</style>
	</head>
	<body>

		<table>
			<tr>
				<th>Source</th>
				<th>Code</th>
				<th>Name</th>
				<th>Case count</th>
				<th>Share of cases (%)</th>
			</tr>

			
				<tr>
					<td><abbr title="KELA drug purchase">PURCH</abbr></td>
					<td>PURCH_ATC(A10BA02)</td>
					<td>Metformin</td>
					<td>43387</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 82.4581409050307%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug reimbursment">REIMB</abbr></td>
					<td>REIMB_KELA(103)_ICD10(E11)</td>
					<td>Diabetes, insulin-treated, Non-insulin-dependent diabetes mellitus</td>
					<td>29905</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 56.83524336241139%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug reimbursment">REIMB</abbr></td>
					<td>REIMB_KELA(215)_ICD10(E11)</td>
					<td>Diabetes, non-insulin-treated, Non-insulin-dependent diabetes mellitus</td>
					<td>27386</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 52.04781724537697%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="Avohilmo: Primary healthcare outpatient">PRIM_OUT</abbr></td>
					<td>PRIM_OUT_ICD10(E11)</td>
					<td>Non-insulin-dependent diabetes mellitus</td>
					<td>22048</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 41.90280707756048%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="Avohilmo: Primary healthcare outpatient">PRIM_OUT</abbr></td>
					<td>PRIM_OUT_ICD10(E119)</td>
					<td>Non-insulin-dependent diabetes mellitus - Without complications</td>
					<td>19228</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 36.54332250033259%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="Outpatient Hilmo">OUTPAT</abbr></td>
					<td>OUTPAT_ICD10(E119)</td>
					<td>Non-insulin-dependent diabetes mellitus - Without complications</td>
					<td>17820</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 33.867381264610295%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="Inpatient Hilmo">INPAT</abbr></td>
					<td>INPAT_ICD10(E119)</td>
					<td>Non-insulin-dependent diabetes mellitus - Without complications</td>
					<td>16960</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 32.23292852120037%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug purchase">PURCH</abbr></td>
					<td>PURCH_ATC(A10BH01)</td>
					<td>Sitagliptin</td>
					<td>12548</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 23.847805842218296%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug purchase">PURCH</abbr></td>
					<td>PURCH_ATC(A10BB12)</td>
					<td>Glimepiride</td>
					<td>9188</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 17.462036984244637%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug purchase">PURCH</abbr></td>
					<td>PURCH_ATC(A10BK03)</td>
					<td>Empagliflozin</td>
					<td>6122</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 11.635022901343673%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug reimbursment">REIMB</abbr></td>
					<td>REIMB_KELA(103)_ICD10(E119)</td>
					<td>Diabetes, insulin-treated, Non-insulin-dependent diabetes mellitus - Without complications</td>
					<td>4893</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 9.29927589942414%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="Avohilmo: Primary healthcare outpatient">PRIM_OUT</abbr></td>
					<td>PRIM_OUT_ICD10(E118)</td>
					<td>Non-insulin-dependent diabetes mellitus - With unspecified complications</td>
					<td>4889</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 9.291673793640838%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug purchase">PURCH</abbr></td>
					<td>PURCH_ATC(A10BD07)</td>
					<td>Metformin and sitagliptin</td>
					<td>4865</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 9.246061158941027%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="Inpatient Hilmo">INPAT</abbr></td>
					<td>INPAT_ICD10(E118)</td>
					<td>Non-insulin-dependent diabetes mellitus - With unspecified complications</td>
					<td>4778</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 9.08071535815421%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug reimbursment">REIMB</abbr></td>
					<td>REIMB_KELA(215)_ICD10(E119)</td>
					<td>Diabetes, non-insulin-treated, Non-insulin-dependent diabetes mellitus - Without complications</td>
					<td>4764</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 9.054107987912651%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug purchase">PURCH</abbr></td>
					<td>PURCH_ATC(A10BH05)</td>
					<td>Linagliptin</td>
					<td>4507</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 8.5656726913355%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug purchase">PURCH</abbr></td>
					<td>PURCH_ATC(A10BB01)</td>
					<td>Glibenclamide</td>
					<td>4308</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 8.187467928616227%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="Outpatient Hilmo">OUTPAT</abbr></td>
					<td>OUTPAT_ICD10(E118)</td>
					<td>Non-insulin-dependent diabetes mellitus - With unspecified complications</td>
					<td>3956</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 7.518482619685653%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug purchase">PURCH</abbr></td>
					<td>PURCH_ATC(A10BK01)</td>
					<td>Dapagliflozin</td>
					<td>3217</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 6.113993576220613%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug purchase">PURCH</abbr></td>
					<td>PURCH_ATC(A10BX01)</td>
					<td>Guar gum</td>
					<td>3135</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 5.958150407662923%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug reimbursment">REIMB</abbr></td>
					<td>REIMB_KELA(285)_ICD10(E11)</td>
					<td>Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults), Non-insulin-dependent diabetes mellitus</td>
					<td>2706</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 5.142824562403786%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug reimbursment">REIMB</abbr></td>
					<td>REIMB_KELA(346)_ICD10(E11)</td>
					<td>Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults), Non-insulin-dependent diabetes mellitus</td>
					<td>2509</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 4.768420852576163%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug purchase">PURCH</abbr></td>
					<td>PURCH_ATC(A10BG03)</td>
					<td>Pioglitazone</td>
					<td>2471</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 4.6962008476347945%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="Inpatient Hilmo">INPAT</abbr></td>
					<td>INPAT_ICD10(E1100)</td>
					<td>Non-insulin dependent diabetes diabetic hypoglycaemic coma</td>
					<td>2371</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 4.506148203052245%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="Outpatient Hilmo">OUTPAT</abbr></td>
					<td>OUTPAT_ICD10(E117)</td>
					<td>Non-insulin-dependent diabetes mellitus - With multiple complications</td>
					<td>2257</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 4.289488188228139%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug purchase">PURCH</abbr></td>
					<td>PURCH_ATC(A10BJ02)</td>
					<td>Liraglutide</td>
					<td>2188</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 4.15835186346618%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="Avohilmo: Primary healthcare outpatient">PRIM_OUT</abbr></td>
					<td>PRIM_OUT_ICD10(E112)</td>
					<td>Non-insulin-dependent diabetes mellitus - With renal complications</td>
					<td>2120</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 4.029116065150046%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="Inpatient Hilmo">INPAT</abbr></td>
					<td>INPAT_ICD10(E117)</td>
					<td>Non-insulin-dependent diabetes mellitus - With multiple complications</td>
					<td>2099</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 3.9892050097877116%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug purchase">PURCH</abbr></td>
					<td>PURCH_ATC(A10BH02)</td>
					<td>Vildagliptin</td>
					<td>1958</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 3.7212307809263163%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="Avohilmo: Primary healthcare outpatient">PRIM_OUT</abbr></td>
					<td>PRIM_OUT_ICD10(E117)</td>
					<td>Non-insulin-dependent diabetes mellitus - With multiple complications</td>
					<td>1920</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 3.6490107759849475%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="Outpatient Hilmo">OUTPAT</abbr></td>
					<td>OUTPAT_ICD10(E113)</td>
					<td>Non-insulin-dependent diabetes mellitus - With ophthalmic complications</td>
					<td>1896</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 3.603398141285136%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug reimbursment">REIMB</abbr></td>
					<td>REIMB_KELA(160)_ICD10(E11)</td>
					<td>exenatide, Non-insulin-dependent diabetes mellitus</td>
					<td>1721</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 3.270806013265674%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="Cause of death">DEATH</abbr></td>
					<td>DEATH_ICD10(E119)</td>
					<td>Non-insulin-dependent diabetes mellitus - Without complications</td>
					<td>1713</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 3.2556018016990707%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="Avohilmo: Primary healthcare outpatient">PRIM_OUT</abbr></td>
					<td>PRIM_OUT_ICD10(E114)</td>
					<td>Non-insulin-dependent diabetes mellitus - With neurological complications</td>
					<td>1615</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 3.069350210008172%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="Inpatient Hilmo">INPAT</abbr></td>
					<td>INPAT_ICD9(2500A)</td>
					<td>Diabetes mellitus without mention of complication</td>
					<td>1579</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 3.000931257958454%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="Outpatient Hilmo">OUTPAT</abbr></td>
					<td>OUTPAT_ICD10(E11)</td>
					<td>Non-insulin-dependent diabetes mellitus</td>
					<td>1482</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 2.8165801927133813%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug purchase">PURCH</abbr></td>
					<td>PURCH_ATC(A10BD03)</td>
					<td>Metformin and rosiglitazone</td>
					<td>1411</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 2.6816428150597713%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug purchase">PURCH</abbr></td>
					<td>PURCH_ATC(A10BG02)</td>
					<td>Rosiglitazone</td>
					<td>1323</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 2.514396487827128%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="Avohilmo: Primary healthcare outpatient">PRIM_OUT</abbr></td>
					<td>PRIM_OUT_ICD10(E113)</td>
					<td>Non-insulin-dependent diabetes mellitus - With ophthalmic complications</td>
					<td>1320</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 2.5086949084896517%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="Outpatient Hilmo">OUTPAT</abbr></td>
					<td>OUTPAT_ICD10(E112)</td>
					<td>Non-insulin-dependent diabetes mellitus - With renal complications</td>
					<td>1225</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 2.3281448961362297%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug purchase">PURCH</abbr></td>
					<td>PURCH_ATC(A10BX07)</td>
					<td>Liraglutide</td>
					<td>1202</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 2.2844327878822432%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="Outpatient Hilmo">OUTPAT</abbr></td>
					<td>OUTPAT_ICD10(E1100)</td>
					<td>Non-insulin dependent diabetes diabetic hypoglycaemic coma</td>
					<td>1198</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 2.2768306820989412%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug purchase">PURCH</abbr></td>
					<td>PURCH_ATC(A10BB07)</td>
					<td>Glipizide</td>
					<td>1186</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 2.2540243647490357%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="Inpatient Hilmo">INPAT</abbr></td>
					<td>INPAT_ICD10(E11)</td>
					<td>Non-insulin-dependent diabetes mellitus</td>
					<td>1077</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 2.046866982154057%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug purchase">PURCH</abbr></td>
					<td>PURCH_ATC(A10BX02)</td>
					<td>Repaglinide</td>
					<td>992</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 1.8853222342588898%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug purchase">PURCH</abbr></td>
					<td>PURCH_ATC(A10BX04)</td>
					<td>Exenatide</td>
					<td>964</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 1.832107493775776%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="Outpatient Hilmo">OUTPAT</abbr></td>
					<td>OUTPAT_ICD10(E115)</td>
					<td>Non-insulin-dependent diabetes mellitus - With peripheral circulatory complications</td>
					<td>886</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 1.6838664310013876%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="Inpatient Hilmo">INPAT</abbr></td>
					<td>INPAT_ICD10(E115)</td>
					<td>Non-insulin-dependent diabetes mellitus - With peripheral circulatory complications</td>
					<td>854</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 1.6230495847349715%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="Inpatient Hilmo">INPAT</abbr></td>
					<td>INPAT_ICD10(E112)</td>
					<td>Non-insulin-dependent diabetes mellitus - With renal complications</td>
					<td>824</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 1.566033791360207%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug reimbursment">REIMB</abbr></td>
					<td>REIMB_KELA(177)_ICD10(E11)</td>
					<td>Insulin glargine 300 U / ml, Non-insulin-dependent diabetes mellitus</td>
					<td>822</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 1.5622327384685557%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="Outpatient Hilmo">OUTPAT</abbr></td>
					<td>OUTPAT_ICD10(E114)</td>
					<td>Non-insulin-dependent diabetes mellitus - With neurological complications</td>
					<td>807</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 1.5337248417811735%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug purchase">PURCH</abbr></td>
					<td>PURCH_ATC(A10BX09)</td>
					<td>Dapagliflozin</td>
					<td>804</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 1.528023262443697%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug reimbursment">REIMB</abbr></td>
					<td>REIMB_KELA(162)_ICD10(E11)</td>
					<td>liraglutide, Non-insulin-dependent diabetes mellitus</td>
					<td>794</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 1.5090179979854421%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug purchase">PURCH</abbr></td>
					<td>PURCH_ATC(A10BJ01)</td>
					<td>Exenatide</td>
					<td>759</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 1.4424995723815497%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug purchase">PURCH</abbr></td>
					<td>PURCH_ATC(A10BJ06)</td>
					<td>Name not found</td>
					<td>757</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 1.4386985194898987%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug purchase">PURCH</abbr></td>
					<td>PURCH_ATC(A10BD08)</td>
					<td>Metformin and vildagliptin</td>
					<td>719</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 1.3664785145485299%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="Avohilmo: Primary healthcare outpatient">PRIM_OUT</abbr></td>
					<td>PRIM_OUT_ICD10(E116)</td>
					<td>Non-insulin-dependent diabetes mellitus - With other specified complications</td>
					<td>661</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 1.2562479806906512%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug reimbursment">REIMB</abbr></td>
					<td>REIMB_KELA(285)_ICD10(E119)</td>
					<td>Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults), Non-insulin-dependent diabetes mellitus - Without complications</td>
					<td>590</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 1.1213106030370412%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug reimbursment">REIMB</abbr></td>
					<td>REIMB_KELA(103)_ICD10(E118)</td>
					<td>Diabetes, insulin-treated, Non-insulin-dependent diabetes mellitus - With unspecified complications</td>
					<td>583</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 1.1080069179162628%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="Outpatient Hilmo">OUTPAT</abbr></td>
					<td>OUTPAT_ICD10(E116)</td>
					<td>Non-insulin-dependent diabetes mellitus - With other specified complications</td>
					<td>579</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 1.1004048121329608%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug reimbursment">REIMB</abbr></td>
					<td>REIMB_KELA(215)_ICD10(E118)</td>
					<td>Diabetes, non-insulin-treated, Non-insulin-dependent diabetes mellitus - With unspecified complications</td>
					<td>575</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 1.0928027063496588%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="Inpatient Hilmo">INPAT</abbr></td>
					<td>INPAT_ICD10(E116)</td>
					<td>Non-insulin-dependent diabetes mellitus - With other specified complications</td>
					<td>529</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 1.0053784898416862%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug purchase">PURCH</abbr></td>
					<td>PURCH_ATC(A10BJ05)</td>
					<td>Dulaglutide</td>
					<td>518</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.9844726989376057%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="Inpatient Hilmo">INPAT</abbr></td>
					<td>INPAT_ICD10(E113)</td>
					<td>Non-insulin-dependent diabetes mellitus - With ophthalmic complications</td>
					<td>513</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.9749700667084783%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug purchase">PURCH</abbr></td>
					<td>PURCH_ATC(A10BD20)</td>
					<td>Metformin and empagliflozin</td>
					<td>498</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.9464621700210958%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug reimbursment">REIMB</abbr></td>
					<td>REIMB_KELA(346)_ICD10(E119)</td>
					<td>Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults), Non-insulin-dependent diabetes mellitus - Without complications</td>
					<td>471</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.8951479559838075%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="Cause of death">DEATH</abbr></td>
					<td>DEATH_ICD10(E117)</td>
					<td>Non-insulin-dependent diabetes mellitus - With multiple complications</td>
					<td>464</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.8818442708630291%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="Inpatient Hilmo">INPAT</abbr></td>
					<td>INPAT_ICD10(E114)</td>
					<td>Non-insulin-dependent diabetes mellitus - With neurological complications</td>
					<td>421</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.8001216336925329%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="Avohilmo: Primary healthcare outpatient">PRIM_OUT</abbr></td>
					<td>PRIM_OUT_ICD10(E115)</td>
					<td>Non-insulin-dependent diabetes mellitus - With peripheral circulatory complications</td>
					<td>405</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.769713210559325%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug purchase">PURCH</abbr></td>
					<td>PURCH_ATC(A10BD15)</td>
					<td>Metformin and dapagliflozin</td>
					<td>405</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.769713210559325%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug purchase">PURCH</abbr></td>
					<td>PURCH_ATC(A10BD05)</td>
					<td>Metformin and pioglitazone</td>
					<td>404</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.7678126841134995%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="Cause of death">DEATH</abbr></td>
					<td>DEATH_ICD10(E118)</td>
					<td>Non-insulin-dependent diabetes mellitus - With unspecified complications</td>
					<td>378</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.7183989965220366%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug reimbursment">REIMB</abbr></td>
					<td>REIMB_KELA(358)_ICD10(E11)</td>
					<td>liraglutide, Non-insulin-dependent diabetes mellitus</td>
					<td>337</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.6404774122431913%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug reimbursment">REIMB</abbr></td>
					<td>REIMB_KELA(310)_ICD10(E11)</td>
					<td>Orlistat, sibutramine and other major and expensive medicines used to treat obesity, Non-insulin-dependent diabetes mellitus</td>
					<td>314</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.596765303989205%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug purchase">PURCH</abbr></td>
					<td>PURCH_ATC(A10BD11)</td>
					<td>Metformin and linagliptin</td>
					<td>235</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.44662371476899104%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="Avohilmo: Primary healthcare outpatient">PRIM_OUT</abbr></td>
					<td>PRIM_OUT_ICD10(E1100)</td>
					<td>Non-insulin dependent diabetes diabetic hypoglycaemic coma</td>
					<td>233</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.44282266187734%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug reimbursment">REIMB</abbr></td>
					<td>REIMB_KELA(160)_ICD10(E119)</td>
					<td>exenatide, Non-insulin-dependent diabetes mellitus - Without complications</td>
					<td>232</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.44092213543151454%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="Cause of death">DEATH</abbr></td>
					<td>DEATH_ICD10(E112)</td>
					<td>Non-insulin-dependent diabetes mellitus - With renal complications</td>
					<td>192</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.3649010775984948%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug reimbursment">REIMB</abbr></td>
					<td>REIMB_KELA(162)_ICD10(E119)</td>
					<td>liraglutide, Non-insulin-dependent diabetes mellitus - Without complications</td>
					<td>171</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.3249900222361594%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="Inpatient Hilmo">INPAT</abbr></td>
					<td>INPAT_ICD10(E111)</td>
					<td>Non-insulin-dependent diabetes mellitus - With ketoacidosis</td>
					<td>160</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.30408423133207896%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug purchase">PURCH</abbr></td>
					<td>PURCH_ATC(A10BH03)</td>
					<td>Saxagliptin</td>
					<td>160</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.30408423133207896%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="Inpatient Hilmo">INPAT</abbr></td>
					<td>INPAT_ICD9(2507A)</td>
					<td>Diabetes mellitus, Diabetes with peripheral circulatory disorders</td>
					<td>140</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.2660737024155691%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="Outpatient Hilmo">OUTPAT</abbr></td>
					<td>OUTPAT_ICD10(E111)</td>
					<td>Non-insulin-dependent diabetes mellitus - With ketoacidosis</td>
					<td>137</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.26037212307809265%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="Outpatient Hilmo">OUTPAT</abbr></td>
					<td>OUTPAT_ICD10(E1101)</td>
					<td>Non-insulin dependent diabetes diabetic coma with hyperglycaemia</td>
					<td>117</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.22236159416158274%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="Inpatient Hilmo">INPAT</abbr></td>
					<td>INPAT_ICD10(E1109)</td>
					<td>Non-insulin-dependent diabetes mellitus - With coma</td>
					<td>111</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.21095843548662982%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="Inpatient Hilmo">INPAT</abbr></td>
					<td>INPAT_ICD9(2505A)</td>
					<td>Diabetes mellitus, Diabetes with ophthalmic manifestations</td>
					<td>106</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.20145580325750234%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug purchase">PURCH</abbr></td>
					<td>PURCH_ATC(A10BX12)</td>
					<td>Empagliflozin</td>
					<td>104</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.19765475036585134%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug reimbursment">REIMB</abbr></td>
					<td>REIMB_KELA(358)_ICD10(E119)</td>
					<td>liraglutide, Non-insulin-dependent diabetes mellitus - Without complications</td>
					<td>84</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.15964422144934148%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug reimbursment">REIMB</abbr></td>
					<td>REIMB_KELA(285)_ICD10(E117)</td>
					<td>Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults), Non-insulin-dependent diabetes mellitus - With multiple complications</td>
					<td>82</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.15584316855769048%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="Outpatient Hilmo">OUTPAT</abbr></td>
					<td>OUTPAT_ICD10(E1109)</td>
					<td>Non-insulin-dependent diabetes mellitus - With coma</td>
					<td>78</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.1482410627743885%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug reimbursment">REIMB</abbr></td>
					<td>REIMB_KELA(103)_ICD10(E112)</td>
					<td>Diabetes, insulin-treated, Non-insulin-dependent diabetes mellitus - With renal complications</td>
					<td>73</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.13873843054526105%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug reimbursment">REIMB</abbr></td>
					<td>REIMB_KELA(215)_ICD10(E112)</td>
					<td>Diabetes, non-insulin-treated, Non-insulin-dependent diabetes mellitus - With renal complications</td>
					<td>71</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.13493737765361005%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug reimbursment">REIMB</abbr></td>
					<td>REIMB_KELA(346)_ICD10(E118)</td>
					<td>Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults), Non-insulin-dependent diabetes mellitus - With unspecified complications</td>
					<td>70</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.13303685120778455%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="Cause of death">DEATH</abbr></td>
					<td>DEATH_ICD9(2500A)</td>
					<td>Diabetes mellitus without mention of complication</td>
					<td>69</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.13113632476195908%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug reimbursment">REIMB</abbr></td>
					<td>REIMB_KELA(346)_ICD10(E117)</td>
					<td>Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults), Non-insulin-dependent diabetes mellitus - With multiple complications</td>
					<td>65</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.1235342189786571%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug reimbursment">REIMB</abbr></td>
					<td>REIMB_KELA(285)_ICD10(E118)</td>
					<td>Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults), Non-insulin-dependent diabetes mellitus - With unspecified complications</td>
					<td>64</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.12163369253283159%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug reimbursment">REIMB</abbr></td>
					<td>REIMB_KELA(103)_ICD10(E117)</td>
					<td>Diabetes, insulin-treated, Non-insulin-dependent diabetes mellitus - With multiple complications</td>
					<td>60</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.11403158674952961%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="Cause of death">DEATH</abbr></td>
					<td>DEATH_ICD10(E115)</td>
					<td>Non-insulin-dependent diabetes mellitus - With peripheral circulatory complications</td>
					<td>57</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.10833000741205315%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="Inpatient Hilmo">INPAT</abbr></td>
					<td>INPAT_ICD10(E1101)</td>
					<td>Non-insulin dependent diabetes diabetic coma with hyperglycaemia</td>
					<td>57</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.10833000741205315%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug reimbursment">REIMB</abbr></td>
					<td>REIMB_KELA(103)_ICD10(E114)</td>
					<td>Diabetes, insulin-treated, Non-insulin-dependent diabetes mellitus - With neurological complications</td>
					<td>56</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.10642948096622763%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug reimbursment">REIMB</abbr></td>
					<td>REIMB_KELA(215)_ICD10(E114)</td>
					<td>Diabetes, non-insulin-treated, Non-insulin-dependent diabetes mellitus - With neurological complications</td>
					<td>55</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.10452895452040215%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug reimbursment">REIMB</abbr></td>
					<td>REIMB_KELA(103)_ICD10(E116)</td>
					<td>Diabetes, insulin-treated, Non-insulin-dependent diabetes mellitus - With other specified complications</td>
					<td>53</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.10072790162875117%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug reimbursment">REIMB</abbr></td>
					<td>REIMB_KELA(346)_ICD10(E112)</td>
					<td>Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults), Non-insulin-dependent diabetes mellitus - With renal complications</td>
					<td>51</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.09692684873710017%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug reimbursment">REIMB</abbr></td>
					<td>REIMB_KELA(215)_ICD10(E116)</td>
					<td>Diabetes, non-insulin-treated, Non-insulin-dependent diabetes mellitus - With other specified complications</td>
					<td>50</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.09502632229127468%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug reimbursment">REIMB</abbr></td>
					<td>REIMB_KELA(285)_ICD10(E112)</td>
					<td>Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults), Non-insulin-dependent diabetes mellitus - With renal complications</td>
					<td>50</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.09502632229127468%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug purchase">PURCH</abbr></td>
					<td>PURCH_ATC(A10BD19)</td>
					<td>Linagliptin and empagliflozin</td>
					<td>48</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.0912252693996237%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug reimbursment">REIMB</abbr></td>
					<td>REIMB_KELA(215)_ICD10(E117)</td>
					<td>Diabetes, non-insulin-treated, Non-insulin-dependent diabetes mellitus - With multiple complications</td>
					<td>47</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.0893247429537982%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug reimbursment">REIMB</abbr></td>
					<td>REIMB_KELA(177)_ICD10(E119)</td>
					<td>Insulin glargine 300 U / ml, Non-insulin-dependent diabetes mellitus - Without complications</td>
					<td>46</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.08742421650797272%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="Cause of death">DEATH</abbr></td>
					<td>DEATH_ICD10(E116)</td>
					<td>Non-insulin-dependent diabetes mellitus - With other specified complications</td>
					<td>44</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.08362316361632173%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug purchase">PURCH</abbr></td>
					<td>PURCH_ATC(A10BH04)</td>
					<td>Alogliptin</td>
					<td>44</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.08362316361632173%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug purchase">PURCH</abbr></td>
					<td>PURCH_ATC(A10BX03)</td>
					<td>Nateglinide</td>
					<td>41</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.07792158427884524%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="Avohilmo: Primary healthcare outpatient">PRIM_OUT</abbr></td>
					<td>PRIM_OUT_ICD10(E111)</td>
					<td>Non-insulin-dependent diabetes mellitus - With ketoacidosis</td>
					<td>38</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.07222000494136875%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug reimbursment">REIMB</abbr></td>
					<td>REIMB_KELA(103)_ICD9(E11)</td>
					<td>Diabetes, insulin-treated, Name not found</td>
					<td>37</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.07031947849554326%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="Inpatient Hilmo">INPAT</abbr></td>
					<td>INPAT_ICD9(2503A)</td>
					<td>Diabetes mellitus, Diabetes with other coma</td>
					<td>35</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.06651842560389228%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug purchase">PURCH</abbr></td>
					<td>PURCH_ATC(A10BD10)</td>
					<td>Metformin and saxagliptin</td>
					<td>35</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.06651842560389228%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="Inpatient Hilmo">INPAT</abbr></td>
					<td>INPAT_ICD9(2506A)</td>
					<td>Diabetes mellitus, Diabetes with neurological manifestations</td>
					<td>34</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.06461789915806677%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug reimbursment">REIMB</abbr></td>
					<td>REIMB_KELA(103)_ICD10(E113)</td>
					<td>Diabetes, insulin-treated, Non-insulin-dependent diabetes mellitus - With ophthalmic complications</td>
					<td>33</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.06271737271224129%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="Inpatient Hilmo">INPAT</abbr></td>
					<td>INPAT_ICD9(2508A)</td>
					<td>Diabetes mellitus, Diabetes with other specified manifestations</td>
					<td>32</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.06081684626641579%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug reimbursment">REIMB</abbr></td>
					<td>REIMB_KELA(346)_ICD10(E113)</td>
					<td>Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults), Non-insulin-dependent diabetes mellitus - With ophthalmic complications</td>
					<td>32</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.06081684626641579%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="Cause of death">DEATH</abbr></td>
					<td>DEATH_ICD10(E110)</td>
					<td>Name not found</td>
					<td>31</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.058916319820590306%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug reimbursment">REIMB</abbr></td>
					<td>REIMB_KELA(103)_ICD10(E110)</td>
					<td>Diabetes, insulin-treated, Name not found</td>
					<td>31</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.058916319820590306%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug reimbursment">REIMB</abbr></td>
					<td>REIMB_KELA(215)_ICD10(E113)</td>
					<td>Diabetes, non-insulin-treated, Non-insulin-dependent diabetes mellitus - With ophthalmic complications</td>
					<td>31</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.058916319820590306%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug reimbursment">REIMB</abbr></td>
					<td>REIMB_KELA(285)_ICD10(E113)</td>
					<td>Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults), Non-insulin-dependent diabetes mellitus - With ophthalmic complications</td>
					<td>31</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.058916319820590306%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug purchase">PURCH</abbr></td>
					<td>PURCH_ATC(A10BK02)</td>
					<td>Kanagliflozin</td>
					<td>30</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.057015793374764805%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="Cause of death">DEATH</abbr></td>
					<td>DEATH_ICD10(E114)</td>
					<td>Non-insulin-dependent diabetes mellitus - With neurological complications</td>
					<td>28</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.053214740483113816%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug reimbursment">REIMB</abbr></td>
					<td>REIMB_KELA(215)_ICD10(E110)</td>
					<td>Diabetes, non-insulin-treated, Name not found</td>
					<td>27</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.05131421403728833%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug reimbursment">REIMB</abbr></td>
					<td>REIMB_KELA(160)_ICD10(E117)</td>
					<td>exenatide, Non-insulin-dependent diabetes mellitus - With multiple complications</td>
					<td>26</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.049413687591462835%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug reimbursment">REIMB</abbr></td>
					<td>REIMB_KELA(285)_ICD10(E114)</td>
					<td>Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults), Non-insulin-dependent diabetes mellitus - With neurological complications</td>
					<td>26</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.049413687591462835%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="Cause of death">DEATH</abbr></td>
					<td>DEATH_ICD9(2507A)</td>
					<td>Diabetes mellitus, Diabetes with peripheral circulatory disorders</td>
					<td>25</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.04751316114563734%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug reimbursment">REIMB</abbr></td>
					<td>REIMB_KELA(346)_ICD10(E114)</td>
					<td>Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults), Non-insulin-dependent diabetes mellitus - With neurological complications</td>
					<td>24</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.04561263469981185%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="Inpatient Hilmo">INPAT</abbr></td>
					<td>INPAT_ICD9(2504A)</td>
					<td>Diabetes mellitus, Diabetes with renal manifestations</td>
					<td>23</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.04371210825398636%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug reimbursment">REIMB</abbr></td>
					<td>REIMB_KELA(162)_ICD10(E117)</td>
					<td>liraglutide, Non-insulin-dependent diabetes mellitus - With multiple complications</td>
					<td>23</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.04371210825398636%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug reimbursment">REIMB</abbr></td>
					<td>REIMB_KELA(162)_ICD10(E112)</td>
					<td>liraglutide, Non-insulin-dependent diabetes mellitus - With renal complications</td>
					<td>22</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.041811581808160865%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug reimbursment">REIMB</abbr></td>
					<td>REIMB_KELA(160)_ICD10(E112)</td>
					<td>exenatide, Non-insulin-dependent diabetes mellitus - With renal complications</td>
					<td>20</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.03801052891650987%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug reimbursment">REIMB</abbr></td>
					<td>REIMB_KELA(162)_ICD10(E118)</td>
					<td>liraglutide, Non-insulin-dependent diabetes mellitus - With unspecified complications</td>
					<td>20</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.03801052891650987%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug reimbursment">REIMB</abbr></td>
					<td>REIMB_KELA(103)_ICD10(E111)</td>
					<td>Diabetes, insulin-treated, Non-insulin-dependent diabetes mellitus - With ketoacidosis</td>
					<td>19</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.036110002470684376%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug reimbursment">REIMB</abbr></td>
					<td>REIMB_KELA(160)_ICD10(E118)</td>
					<td>exenatide, Non-insulin-dependent diabetes mellitus - With unspecified complications</td>
					<td>19</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.036110002470684376%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="Avohilmo: Primary healthcare outpatient">PRIM_OUT</abbr></td>
					<td>PRIM_OUT_ICD10(E1109)</td>
					<td>Non-insulin-dependent diabetes mellitus - With coma</td>
					<td>17</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.03230894957903339%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug reimbursment">REIMB</abbr></td>
					<td>REIMB_KELA(215)_ICD10(E111)</td>
					<td>Diabetes, non-insulin-treated, Non-insulin-dependent diabetes mellitus - With ketoacidosis</td>
					<td>16</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.030408423133207896%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug purchase">PURCH</abbr></td>
					<td>PURCH_ATC(A10BD09)</td>
					<td>Pioglitazone and alogliptin</td>
					<td>15</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.028507896687382402%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="Cause of death">DEATH</abbr></td>
					<td>DEATH_ICD10(E111)</td>
					<td>Non-insulin-dependent diabetes mellitus - With ketoacidosis</td>
					<td>14</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.026607370241556908%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="Outpatient Hilmo">OUTPAT</abbr></td>
					<td>OUTPAT_ICD10(E110)</td>
					<td>Name not found</td>
					<td>14</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.026607370241556908%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug purchase">PURCH</abbr></td>
					<td>PURCH_ATC(A10BD13)</td>
					<td>Metformin and alogliptin</td>
					<td>14</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.026607370241556908%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug reimbursment">REIMB</abbr></td>
					<td>REIMB_KELA(285)_ICD10(E116)</td>
					<td>Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults), Non-insulin-dependent diabetes mellitus - With other specified complications</td>
					<td>14</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.026607370241556908%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug reimbursment">REIMB</abbr></td>
					<td>REIMB_KELA(358)_ICD10(E112)</td>
					<td>liraglutide, Non-insulin-dependent diabetes mellitus - With renal complications</td>
					<td>14</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.026607370241556908%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="Cause of death">DEATH</abbr></td>
					<td>DEATH_ICD10(E113)</td>
					<td>Non-insulin-dependent diabetes mellitus - With ophthalmic complications</td>
					<td>13</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.024706843795731417%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug purchase">PURCH</abbr></td>
					<td>PURCH_ATC(A10BJ03)</td>
					<td>Lixisenatide</td>
					<td>12</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.022806317349905927%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug purchase">PURCH</abbr></td>
					<td>PURCH_ATC(A10BK04)</td>
					<td>Name not found</td>
					<td>12</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.022806317349905927%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug reimbursment">REIMB</abbr></td>
					<td>REIMB_KELA(160)_ICD10(E114)</td>
					<td>exenatide, Non-insulin-dependent diabetes mellitus - With neurological complications</td>
					<td>12</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.022806317349905927%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug purchase">PURCH</abbr></td>
					<td>PURCH_ATC(A10BD21)</td>
					<td>Saxagliptin and dapagliflozin</td>
					<td>11</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.020905790904080433%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug reimbursment">REIMB</abbr></td>
					<td>REIMB_KELA(103)_ICD10(E115)</td>
					<td>Diabetes, insulin-treated, Non-insulin-dependent diabetes mellitus - With peripheral circulatory complications</td>
					<td>11</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.020905790904080433%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug reimbursment">REIMB</abbr></td>
					<td>REIMB_KELA(346)_ICD10(E116)</td>
					<td>Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults), Non-insulin-dependent diabetes mellitus - With other specified complications</td>
					<td>10</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.019005264458254935%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug reimbursment">REIMB</abbr></td>
					<td>REIMB_KELA(160)_ICD10(E113)</td>
					<td>exenatide, Non-insulin-dependent diabetes mellitus - With ophthalmic complications</td>
					<td>9</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.01710473801242944%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug reimbursment">REIMB</abbr></td>
					<td>REIMB_KELA(162)_ICD10(E114)</td>
					<td>liraglutide, Non-insulin-dependent diabetes mellitus - With neurological complications</td>
					<td>9</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.01710473801242944%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug reimbursment">REIMB</abbr></td>
					<td>REIMB_KELA(215)_ICD10(E115)</td>
					<td>Diabetes, non-insulin-treated, Non-insulin-dependent diabetes mellitus - With peripheral circulatory complications</td>
					<td>9</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.01710473801242944%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug reimbursment">REIMB</abbr></td>
					<td>REIMB_KELA(310)_ICD10(E119)</td>
					<td>Orlistat, sibutramine and other major and expensive medicines used to treat obesity, Non-insulin-dependent diabetes mellitus - Without complications</td>
					<td>8</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.015204211566603948%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug purchase">PURCH</abbr></td>
					<td>PURCH_ATC(A10BB02)</td>
					<td>Chlorpropamide</td>
					<td>7</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.013303685120778454%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug purchase">PURCH</abbr></td>
					<td>PURCH_ATC(A10BX10)</td>
					<td>Lixisenatid</td>
					<td>7</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.013303685120778454%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug reimbursment">REIMB</abbr></td>
					<td>REIMB_KELA(358)_ICD10(E117)</td>
					<td>liraglutide, Non-insulin-dependent diabetes mellitus - With multiple complications</td>
					<td>7</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.013303685120778454%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug reimbursment">REIMB</abbr></td>
					<td>REIMB_KELA(160)_ICD10(E116)</td>
					<td>exenatide, Non-insulin-dependent diabetes mellitus - With other specified complications</td>
					<td>6</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.011403158674952963%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug reimbursment">REIMB</abbr></td>
					<td>REIMB_KELA(162)_ICD10(E113)</td>
					<td>liraglutide, Non-insulin-dependent diabetes mellitus - With ophthalmic complications</td>
					<td>6</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.011403158674952963%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug reimbursment">REIMB</abbr></td>
					<td>REIMB_KELA(177)_ICD10(E118)</td>
					<td>Insulin glargine 300 U / ml, Non-insulin-dependent diabetes mellitus - With unspecified complications</td>
					<td>6</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.011403158674952963%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="Cause of death">DEATH</abbr></td>
					<td>DEATH_ICD9(2505A)</td>
					<td>Diabetes mellitus, Diabetes with ophthalmic manifestations</td>
					<td>5</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.009502632229127467%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="Cause of death">DEATH</abbr></td>
					<td>DEATH_ICD9(2506A)</td>
					<td>Diabetes mellitus, Diabetes with neurological manifestations</td>
					<td>5</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.009502632229127467%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="Cause of death">DEATH</abbr></td>
					<td>DEATH_ICD9(2508A)</td>
					<td>Diabetes mellitus, Diabetes with other specified manifestations</td>
					<td>5</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.009502632229127467%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug reimbursment">REIMB</abbr></td>
					<td>REIMB_KELA(285)_ICD10(E115)</td>
					<td>Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults), Non-insulin-dependent diabetes mellitus - With peripheral circulatory complications</td>
					<td>5</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.009502632229127467%"></div>
						</div>
						
					</td>
				</tr>
			

		</table>

	</body>
</html>
